Detalhe da pesquisa
1.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35921449
2.
Phenotypic characterization of Plasmodium berghei responsive CD8+ T cells after immunization with live sporozoites under chloroquine cover.
Malar J
; 13: 92, 2014 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24620841
3.
Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studies.
Malar J
; 13: 215, 2014 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24893777
4.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36708738
5.
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
Clin Infect Dis
; 54(2): 232-9, 2012 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22052893
6.
Mosquito bisection as a variable in estimates of PCR-derived malaria sporozoite rates.
Malar J
; 11: 145, 2012 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-22551078
7.
Distribution of Triatoma dimidiata sensu lato (Reduviidae: Triatominae) and Risk Factors Associated with Household Invasion in Northern Belize, Central America.
J Med Entomol
; 59(2): 764-771, 2022 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35064668
8.
Effect of temperature on laboratory reared Anopheles dirus Peyton and Harrison and Anopheles sawadwongporni Rattanarithikul and Green.
Southeast Asian J Trop Med Public Health
; 42(1): 63-70, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21323167
9.
Molecular Detection and Identification of Rickettsia Species in Ticks (Acari: Ixodidae) Collected From Belize, Central America.
J Med Entomol
; 54(6): 1718-1726, 2017 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28981693
10.
Effects of Preexposure to DEET on the Downstream Blood-Feeding Behaviors of Aedes aegypti (Diptera: Culicidae) Mosquitoes.
J Med Entomol
; 53(5): 1100-1104, 2016 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27288690
11.
Dengue Virus-1 Infection Did Not Alter the Behavioral Response of Aedes aegypti (Diptera: Culicidae) to DEET.
J Med Entomol
; 53(3): 687-691, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27026163
12.
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
PLoS Negl Trop Dis
; 10(2): e0004423, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26919472
13.
Detection of Dengue Virus in Mosquito Extracts and Human Clinical Samples Using a Field Expedient Molecular Platform.
Mil Med
; 180(9): 937-42, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26327544
14.
Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.
Clin Vaccine Immunol
; 20(6): 803-10, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23536694
15.
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Vaccine
; 31(43): 4975-83, 2013 Oct 09.
Artigo
Inglês
| MEDLINE | ID: mdl-24029408
16.
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
Hum Vaccin Immunother
; 9(10): 2165-77, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23899517
17.
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
PLoS One
; 8(2): e55571, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23457473
18.
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.
Science
; 341(6152): 1359-65, 2013 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23929949
19.
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.
PLoS One
; 6(10): e25868, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22003411